Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer

  • Authors:
    • Ajay Kumar Gautam
    • Changming Wang
    • Jinrong Zeng
    • Jiying Wang
    • Jingyan Lu
    • Jianghong Wei
    • Guojin Huang
    • Bifan Mo
    • Miao Luo
    • Biwen Mo
  • View Affiliations

  • Published online on: September 30, 2015     https://doi.org/10.3892/ol.2015.3772
  • Pages: 3629-3634
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is the most frequent cancer worldwide, in terms of incidence and mortality. Due to challenges in the diagnosis of the disease, the 5‑year overall survival rate is only ~16%. Previous studies have suggested that malignant transformations originate from adult stem cells, and malignant lesions may therefore express stem‑cell‑associated markers. The purpose of the present study is to investigate the expression and clinical significance of the stem cell‑associated markers Sal‑like protein 4 (SALL4) and leucine‑rich repeat‑containing G‑protein coupled receptor 5 (LGR5) in lung cancer, and to provide novel diagnostic markers and targets for the treatment of lung cancer. The expression of the stem cell‑associated markers SALL4 and LGR5 was analyzed by immunohistochemistry performed on 135 human lung cancer tissue specimens and 10 non‑cancer lung tissue specimens. The clinical significance of the expression of these markers and correlation between their expression and clinical parameters was also assessed. SALL4 expression was highly upregulated in lung cancer tissues, but was not present in non‑cancerous lung tissues, and the sensitivity and specificity of SALL4 reached 88% and 100%, respectively. By contrast, LGR5 demonstrated 97% sensitivity, but the specificity was poor. Therefore, SALL4 may be an extremely useful diagnostic marker for lung cancer, but LGR5 is not as useful.
View Figures
View References

Related Articles

Journal Cover

December-2015
Volume 10 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gautam AK, Wang C, Zeng J, Wang J, Lu J, Wei J, Huang G, Mo B, Luo M, Mo B, Mo B, et al: Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer. Oncol Lett 10: 3629-3634, 2015.
APA
Gautam, A.K., Wang, C., Zeng, J., Wang, J., Lu, J., Wei, J. ... Mo, B. (2015). Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer. Oncology Letters, 10, 3629-3634. https://doi.org/10.3892/ol.2015.3772
MLA
Gautam, A. K., Wang, C., Zeng, J., Wang, J., Lu, J., Wei, J., Huang, G., Mo, B., Luo, M., Mo, B."Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer". Oncology Letters 10.6 (2015): 3629-3634.
Chicago
Gautam, A. K., Wang, C., Zeng, J., Wang, J., Lu, J., Wei, J., Huang, G., Mo, B., Luo, M., Mo, B."Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer". Oncology Letters 10, no. 6 (2015): 3629-3634. https://doi.org/10.3892/ol.2015.3772